6 days ago
7
Adé Hennis, The Motley Fool
Sun, March 1, 2026 astatine 5:18 PM CST 3 min read
On Feb. 24, 2026, Ardelyx (NASDAQ:ARDX) President and CEO Michael Raab reported the merchantability of 41,666 shares of Common Stock for astir $261,000, according to a SEC Form 4 filing.
| Shares sold (direct) | 41,666 |
| Transaction value | $261,000 |
| Post-transaction shares (direct) | 1,836,153 |
| Post-transaction shares (indirect) | 25,364 |
| Post-transaction worth (direct ownership) | ~$12M |
Transaction worth based connected SEC Form 4 weighted mean acquisition terms ($6.25). Post-transaction worth based connected closing terms of Feb. 24 ($6.56).
-
What is the discourse of the derivative enactment successful this filing?
This merchantability progressive an enactment workout of 20,833 shares prior, arsenic mentioned successful the SEC filing. -
How did the transaction impact Raab’s wide ownership and liquidity profile?
Following the sale, Raab retains 1,836,153 shares straight and 25,364 shares indirectly.
| Price (as of Feb. 28, 2026) | $6.55 |
| Market capitalization | $1.61 billion |
| Revenue (TTM) | $407.32 million |
| Net Loss (TTM) | $61.60 |
Ardelyx is simply a biotech institution focused connected innovative therapies for patients with gastrointestinal conditions and chronic kidney disease. Along with a beardown lawsuit basal successful the U.S., it besides partners with pharmaceutical entities successful Canada, China, and Japan.
On Feb. 19, 2026, Ardelyx reported its Q4 net for fiscal twelvemonth 2025, showing affirmative growth, including present having 4 consecutive years of gross maturation and a declining nett loss. Its therapy treatment, IBSRELA, which is for patients with irritable bowel syndrome with constipation, has been highly successful. Its XPHOZAH treatment, which helps patients connected dialysis negociate chronic kidney disease, has besides been a fashionable staple of the company.
On Feb. 24, the pharmaceutical institution announced a multi-year concern with the Ladies Professional Golf Association (LPGA), aiming to amended and mobilize women successful health. Ardelyx, present an authoritative firm pharmaceutical selling spouse of the LPGA Tour, hopes to enactment women’s digestive health, including those with conditions specified arsenic irritable bowel syndrome and constipation.
The company’s banal terms grew astir 18% successful 2025, and is presently up 15% this year. However, investors whitethorn privation to show the increasing speculation that Ardelyx could beryllium acquired, arsenic rumors suggest the Indian pharmaceutical institution Zydus Lifesciences is exploring a bulk involvement successful Ardelyx. This remains conscionable rumors for now, but it is thing to support an oculus on.
Before you bargain banal successful Ardelyx, see this:
English (CA) · 
English (US) · 
Spanish (MX) ·